Biopharmaceuticals Market Forecast to Surge at 7.98% CAGR Through 2028 Driven by Chronic Disease Prevalence and Advancements in Personalized Medicines

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to's offering.

The biopharmaceutical industry is witnessing a significant upward trajectory, with a new comprehensive analysis projecting substantial growth by 2028. The market's expansion is intricately linked to the increasing burden of chronic diseases worldwide and the subsequent demand for innovative therapeutic options.

According to the latest market insights, the global biopharmaceuticals market is expected to burgeon at a CAGR of 7.98%, attaining a market valuation of USD 713.61 billion by the end of the forecast period. This growth is propelled by the rising incidence of various chronic and terminal illnesses, which has sparked a robust demand for biopharmaceuticals and personalized medicines.

Market Dynamics: Key Growth Propellers

The market's robust growth curve can be attributed to several pivotal factors:

  • The alarming rise in cancer cases globally, as underscored by Globocan Statistics, stresses the need for effective biopharmaceuticals in oncology.
  • Strides in research and development across biopharmaceutical firms are churning out innovative treatments capable of managing previously untreatable conditions.
  • The burgeoning investment in medical research and biotechnological advancements is catalyzing the market's expansion.
  • Enhancements in healthcare infrastructure and regulatory approvals of new biopharmaceuticals are propelling market growth.

Segment Analysis: Monoclonal Antibodies Lead

In the biopharmaceuticals market analysis, the product type segment dominated by monoclonal antibodies is anticipated to maintain its lead. Monoclonal antibodies, essential in immunotherapy, have demonstrated efficacy in treating cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases, to name a few.

Regional Outlook: North America Takes the Lead

North America emerges as the dominant force in the biopharmaceuticals market, a position attributable to the region's advanced healthcare systems and significant research and development activities. The U.S., in particular, continues to be the epicenter of biopharmaceutical innovation and market consumption.

Contributing to the regional market dominance are factors such as:

  • A significant portion of the global market share attributable to the region's extensive healthcare infrastructure.
  • An aging population and rising incidence of chronic diseases.
  • Continuous FDA approvals and introduction of new biopharmaceuticals streamline the drug pipeline, enhancing the treatment landscape.

Competitive Landscape: Pivotal Players in the Market

Key players operating in the global biopharmaceuticals market are undertaking strategic initiatives to consolidate their market presence. Recent developments including new partnerships, clinical trials, and FDA approvals reflect the dynamic nature of the market and hint at the potential for revolutionary treatments.

The landscape of the biopharmaceuticals industry promises a future of groundbreaking therapeutic discoveries, bringing hope and advanced care to millions worldwide. Stakeholders in the industry and entities in the healthcare sector are poised to witness this unprecedented growth and transformation that holds potential to redefine medical treatments and patient outcomes.

With this new research publication, industry analysts, investors, and healthcare practitioners can gain an in-depth understanding of the current trends, dynamics, and projected growth trajectory of the global biopharmaceuticals market.

For individuals and entities seeking comprehensive insights into the biopharmaceuticals market, this report sheds light on the pivotal trends and opportunities that are shaping the industry's future.

A selection of companies mentioned in this report includes

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Johnson & Johnson
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • GSK plc.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Sanofi SA
  • AstraZeneca PLC
  • Bayer AG
  • Takeda Pharmaceutical Company Limited
  • UCB S.A.
  • Boehringer Ingelheim International GmbH
  • Biogen
  • Serum Institute of India

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data